We aimed to evaluate the relationship between different types of obesity and cardiovascular risk indicators. A total of 623 overweight (body mass index [BMI] > 25 kg/m 2 ), and 2559 obese (BMI > 30 kg/m 2 ) women were divided into four groups according to their BMI and waistto-hip ratio (WHR): simple overweight (BMI 25 -30 kg/m 2 and WHR < 0.8, n = 371), abdominal adiposity (BMI 25 -30 kg/m 2 and WHR > 0.8, n = 252), peripheral (pure) obesity (BMI > 30 kg/m 2 and WHR < 0.8, n = 918) and central obesity (BMI > 30 kg/m 2 and WHR > 0.8, n = 1641). The levels of the risk indicators measured (clinical, anthropometric and laboratory) were significantly higher in the central obesity group. Total body fat and abdominal fat accumulation seems to result in more serious hyperinsulinaemia and insulin resistance in central obesity. Measuring BMI and WHR in obese patients may reveal their risk for coronary heart disease.
Introduction
Many metabolic defects may be noticed before diseases like stroke, non-insulin dependent diabetes mellitus and cardiovascular disease develop. 1 Physicians have long been familiar with such groups of symptoms. 2 Over the past ten years, different names have been given to the disorders that may predict or indicate risk for diseases such as hypertension and elevated levels of cholesterol, glucose and triglycerides. Reaven 3 started a new era by giving the name 'syndrome X' to the following group of conditions: insulin-evoked glucose uptake resistance; glucose intolerance; hyperinsulinaemia; increased levels of very low-density lipoproteins (VLDL); decreased levels of high-density lipoprotein cholesterol (HDL-C) levels; hypertension; and increasing predisposition to coronary heart disease.
Central obesity is the most prominent feature of the metabolic syndrome (also called syndrome X). It is associated with cardiovascular risk factors such as diabetes mellitus or impaired glucose tolerance, low HDL-C levels, hypertriglyceridaemia and hypertension, all of which are thought to develop as a result of insulin resistance. 3 -9 In a previous study undertaken at our department we had found that, among all obese women, those with central obesity had more risk factors. 10 The aim of the present study was to evaluate the differences in risk indicators among overweight and obese women divided into four groups: pure overweight, abdominal adiposity, pure obesity (peripheral obesity) and central obesity.
Patients and methods
Overweight and obese women who attended the out-patient obesity clinic at Istanbul Medical Faculty between 1998 and 2002 were included in the study. 'Overweight' was defined as body mass index (BMI) > 25 kg/m 2 and 'obesity' as BMI > 30 kg/m 2 . 11 Ethical approval and informed consent were not required as the study did not involve administering treatment and all metabolic and anthropometrical measurements taken were part of routine clinic assessment.
ASSESSMENT OF PATIENTS
Standardized clinical, anthropometric and laboratory evaluation of all subjects was done according to our out-patient obesity clinic patient assessment protocol. This included assessing daily eating habits, physical activity patterns, smoking and alcohol intakes, prescribed drug use, family history of cardiovascular disease and diabetes, electrocardiogram, biochemical (glucose, uric acid, and total cholesterol, LDL-C, HDL-C and triglyceride concentrations) and fasting insulin levels. General physical examination included measuring height (to the nearest cm, without shoes), weight (to the nearest 0.1 kg, without coats), waist circumference (the minimum circumference measured between the iliac crest and the lateral costal margin) and hip circumference (as the maximum value over the hips). BMI was calculated as the ratio of weight (kg) divided by height (m) squared (kg/m 2 ). 12 Waist-to-hip ratio (WHR) was calculated as waist circumference (cm) divided by hip circumference (cm). 9, 13 Systolic and diastolic blood pressures were measured from the right arm with subjects in an upright sitting position, and after at least 5-min rest. A mercury sphygmomanometer with appropriate cuff size was used. Two readings were recorded, and the average was defined as the patient's blood pressure.
Venous blood samples were drawn between 8 and 9 am, after an overnight fast of 12 -14 h. Glucose, total cholesterol, triglycerides, LDL-C, VLDL-C, HDL-C, uric acid, and insulin levels were analysed using a Technicon DAX-72™ auto-analyser (Technicon, Bayer Corporation, Tarrytown, NY, USA) in the Central Biochemistry Laboratory, Istanbul Faculty of Medicine.
Insulin resistance was calculated for some of the patients using the computer-derived homeostasis model assessment (HOMA) formula: 14 HOMA = fasting insulin (mU/ml) × fasting glucose (mmol/l)/22.5.
Patients were divided into four groups according to their BMI and WHR: 
RISK INDICATORS

STATISTICAL METHODS
The data were stored in a computer program (DBase IV v 2.0 ® ; Borland, CA, USA) and are presented as mean ± SD. SPSS/PC + version 3.0 statistical software (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis. 16, 17 Analysis of variance and Student's unpaired t-test were used to compare groups analyses. 18 A P-value < 0.05 was considered significant.
Results
A total of 623 overweight and 2559 obese women were included in the study. The number of women in each of the four groups were: overweight 371, abdominal adiposity 252, peripheral obesity 918 and central obesity 1641. Table 1 shows the mean ± SD of the various clinical, anthropometric and laboratory parameters.
In the central obesity group, all parameters except height and hip circumference were higher than in all other groups. The peripheral obesity group generally had the second highest values, although age, height, WHR, glucose and cholesterol levels were the second highest in the abdominal adiposity group.
There was a statistically significant difference between all groups for all the parameters.
The total risk was highest for the central obesity group (2.15 ± 1.29), followed by peripheral obesity (1.62 ± 1.24), abdominal adiposity (1.46 ± 1.25) and overweight groups (0.94 ± 0.91). No significant difference in risk was found between the peripheral obesity and abdominal adiposity groups.
Discussion
Risk indicators associated with obesity are variable. Studies have shown that there is a relationship between intra-abdominal fat and some cardiovascular risk factors, 4, 5, 8, 9 and that intra-abdominal fat is a more important sign of cardiovascular disease and death than total body fat. 19 -21 Visceral fat accumulation is also associated with insulin resistance and compensatory hyperinsulinism. 3 -5,8,9,22 Hyperinsulinism causes increased hormone-sensitive lipase (HSL) activity and decreased lipoprotein lipase (LPL) activity. 3 As a result, triglyceride and free fatty acid levels are raised and HDL-C levels lowered. 4 Raised free fatty acid levels lead to abnormalities in glucose metabolism. 23 In our study, the highest levels for all the risk indicators were found in the central obesity group. In these patients, abdominal fat accumulation was more prominent 3 -5,8 and the highest insulin and HOMA levels were seen. Higher triglyceride and glucose levels, showing insulin resistance, and lower HDL-C levels were also observed in this group. These findings support the notion of central obesity as a cause of insulin resistance. 6 Hip circumference was greatest in the pure obese (peripheral obesity) group. Other parameters, such as weight, BMI, waist circumference, systolic and diastolic blood pressures, uric acid, triglyceride, insulin and HOMA levels were higher in this group compared with the abdominal adiposity group. On the contrary, glucose and cholesterol levels were found to be higher in the abdominal adiposity group. There was no significant difference between total risk of peripheral obesity and abdominal adiposity groups. These findings support the theory that both total body fat and abdominal adiposity are effective risk indicators. 12, 13 It was also seen that in women with central obesity, the presence of abdominal fat 
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TABLE 1 (continued):
Mean ± SD of the clinical, anthropometric and laboratory parameters of the overweight and obese women in the four study groups
